Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
Many diabetic patients continue to have hyperglycaemia on maximal sulphonylurea therapy. Five different therapeutic options, with the prime aim of achieving normal fasting plasma glucose concentrations, have been compared in 15 asymptomatic, sulphonylurea-treated type 2 diabetic patients in a random...
Үндсэн зохиолчид: | Holman, R, Steemson, J, Turner, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1987
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
-н: Holman, R, зэрэг
Хэвлэсэн: (1987) -
Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM
-н: Rachman, J, зэрэг
Хэвлэсэн: (1996) -
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
-н: Matthews, DR, зэрэг
Хэвлэсэн: (1998) -
UKPDS 18: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy
-н: Eeley, E, зэрэг
Хэвлэсэн: (1996) -
COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
-н: Holman, R, зэрэг
Хэвлэсэн: (1977)